Overcoming Bacteriophage Resistance in Phage Therapy

Area of Science:

• Microbiology
• Infectious Diseases
• Biotechnology

Background:

• Antibiotic resistance in pathogenic bacteria is a critical global health crisis, projected to cause over ten million deaths annually by 2050.
• Phage therapy, utilizing bacteriophages (viruses that infect bacteria), presents a viable alternative to conventional antibiotics.
• A significant hurdle for phage therapy is the rapid development of bacterial resistance to phages.

Approach:

• This review synthesizes current research on mechanisms of phage resistance in bacteria.
• It examines various strategies proposed to mitigate or circumvent phage resistance during therapeutic applications.
• The focus is on understanding and overcoming bacterial adaptation to bacteriophage treatments.

Key Points:

• Bacterial resistance to phages can emerge through multiple mechanisms, including receptor modification, CRISPR-Cas systems, and abortive infection.
• Strategies to overcome resistance include using phage cocktails, genetically engineered phages, and combination therapies with antibiotics.
• Understanding the evolutionary dynamics between phages and bacteria is crucial for developing effective phage therapy protocols.

Conclusions:

• Overcoming phage resistance is essential for the successful clinical implementation of phage therapy.
• A multi-faceted approach combining innovative phage selection and application strategies is necessary.
• Further research into the molecular basis of phage-bacterial interactions will pave the way for robust phage-based treatments against resistant pathogens.